NRGN and Alzheimer disease: Current research also indicates a strong association between CSF t-tau and biomarkers that reflect synaptic degeneration, such as Ng and SNAP25, in both mild cognitive impairment (MCI) and preclinical AD, when t-tau levels have been found to triple20–23, before substantial neuronal loss.